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1. INTRODUCTION [‘251]insulin binding, dissociation and degradation 
have been detailed in [ 12,131. 
Following initial binding to a specific cell-mem- 
brane receptor, insulin is taken up into the cell and 
degraded [l-4]. Very little is known of this endo- 
cytotic-intracellular degradation pathway. The 
structure of the insulin molecule is well understood, 
and one portion of the molecule which is important 
in binding to the receptor has been determined to 
be amino acids 22-26 of the B chain [5,6]. However, 
it is not known if this sequence is important in 
determining whether the molecule is internalized 
and processed intracellularly. In (71 it was shown 
that a Leu-Phe substitution in position 24 of the B 
chain results in an insulin molecule ([LeuB24]- 
insulin) with a low binding affinity for the insulin 
receptor. Furthermore, the molecule antagonizes 
the biological action of normal insulin. Here, we 
show that the amino acid substitution does not alter 
the rate of internalization nor the rate or extent of 
degradation of receptor bound analog to low-M, 
products. This demonstrates that the receptor bind- 
ing region of the insulin molecule is not recognized 
in the degradative processes subsequent to the bind- 
ing event. 
3. RESULTS AND DISCUSSION 
The potency of [Leu B24]insulin to inhibit binding 
of [ ‘251]insulin to adipocytes is shown in fi 
9. 
1. It can 
be seen that the EC50 for inhibition of [I* Ilinsulin 
binding is - 70 ng/ml. This is compared to the EC50 
for insulin’s ability to inhibit [‘251]insulin binding, 
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2. EXPERIMENTAL 
[LeuB24]Insulin was prepared as in 171. Adipo- 
cytes were isolated from rat epididymal fat pads by 
the method in [8] as in [9]. Insulin and [LeuB24]in- 
sulin were iodinated by a modification [lo] of the 
method in [ 111. The techniques for measurement of 
Fig. 1. Effect of insulin and [LeuB24]insulin on [ 1251]insu- 
lin binding by adipocytes. Adipocytes (-2 x 105/ml) 
were incubated with (‘251]insulin (0.3 q/ml) plus the 
indicated concentration of insulin (0) or [LeuB24]insulin 
(o), for 90 min at 24°C. At the end of this period [1251]- 
insulin binding to the cells was determined. 
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Fig.2. Effects of insulin and anti-insulin receptor antibodies on binding of [‘251]insulin and t251-labeled [LeuB24]insulin to 
adipocytes. Adipocytes (-2 x 105) were incubated with 0.3 ng [1251]insulin (a) or 1 ng 12SI-labeled [LeuB24]insulin (o) in 1 
ml buffer for 90 min at 24°C. At the end of this period the amount of [1251]insulin or 1251-labeled [LeuB24]insulin bound 
was determined. (A) Effect of insulin, at the indicated concentrations, added together with the labeled hormones. (B) 
Effects of a serum containing anti-insulin receptor antibodies. The serum, at the indicated dilutions, was added to the cells 
15 min before the labeled hormone. 
which is - 10 ng/ml. By corn aring these EC5u- 
values it can be seen that [LeuBP4]insulin has - 15% 
the binding affinity of insulin. 
In order to ensure that ‘251-labeled [LeuB24]- 
insulin binds only to the insulin receptors, the exper- 
iments described in fig.2 were performed. Fig.2A 
shows the effect of insulin on binding of [‘251]insu- 
lin and of ‘251-labeled [LeuB24]insulin, It can be 
seen that insulin is equally potent at inhibiting bind- 
ing of the two labeled molecules, strongly suggest- 
ing that they bind to the same receptors. A second 
line of evidence that ‘251-labeled [LeuB24]insulin 
binds to the insulin receptor is shown in tig.2B. This 
experiment demonstrates that a serum containing 
anti-insulin receptor antibodies is equally potent at 
inhibiting binding of [‘251]insulin and of ‘251- 
labeled [LeuB24]insulin to adipocytes. Taken to- 
gether these results demonstrate that [LeuB24]insu- 
lin binds with low affinity to the same population of 
insulin receptors as does native insulin. 
Chloroquine can be used to assess the amount of 
insulin internalized by adipocytes [14]. This drug 
causes an increase in the amount of cell-associated 
256 
[ ‘251]insulin when adipocytes are incubated with 
[ 1251]insulin at 37°C. Chloroquine acts by inhibiting 
intracellular processing of insulin and subsequent 
release of degradation products [3,4]. Therefore the 
difference between cell-associated insulin in the 
presence and absence of chloroquine provides an 
estimate of the amount of hormone internalized 
[14]. Thus, we have compared the actions of the 
drug on the association of insulin and [LeuB24]in- 
sulin to isolated adipocytes (fig.3). To compare the 
chloroquine effect independent1 
1 
of the difference 
in binding affinities of [’ 51]insulin and 
B24]insulin it was necessary to use a higher 
Lzentration of [LeuB24]insulin than of insulin, 
such that the amounts bound were ap roximately 
equal. This was achieved by using ‘: 251-labeled 
[LeuB24]insulin at 1 ng/ml and [1251]insulin at 0.2 
ng/ml (fig.3). Under these conditions it can be seen 
that the chloroquine-mediated increase in cell-as- 
sociated radioactive material is approximately 
equal for [Leu B24]insulin and insulin. Since the 
chloroquine effect provides an estimate of inter- 
nalization, this suggests that once bound, 
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Fig.3. Effect of chloroquine on the association of 
[ ‘251]insulin and 1251-labeled [LeuB24]insulin. Adipocytes 
(-2 X 105/ml) were incubate&with 0.2 ng/ml [1251]insu- 
lin (o,o) or 1 ng/ml 1251-labeled [LeuB24]insulin (~,a) in 
the presence (open symbols) or absence (closed symbols) 
of 0.2 mM chloroquine, at 37°C. At the indicated times 
the amount of t251-labeled material bound to the cells 
was determined. 
[Leu B24]insulin is internalized by adipocytes at ap- 
proximately the same rate as insulin. 
When isolated adipocytes are incubated with 
[‘251]insulin the intracellular, or receptor-mediated, 
degradation forms only a portion of the total rate of 
insulin degradation [ 151. Therefore, to study recep- 
tor-mediated degradation alone, the trichloroacetic 
acid solubility of material released from cells which 
have been pre-loaded with ‘251-labeled hormone is 
measured [15]. We have used this approach to 
corn are 
< 
receptor-mediated degradation of 
[Leu 24]insulin and of insulin (tig.4). Since the ap- 
parent affinity constant (KJ of insulin is related to 
the ratio of the association and dissociation rate 
constants, a potential problem was that the low af- 
finity of [LeuB24 Iinsulin might be due to a fast dis- 
sociation rate, which would complicate interpreta- 
tion of the results. However, [LeuB24]insulin disso- 
ciates from adipocytes at about the same rate as 
insulin and its low affinity is probably due to a slow 
association rate constant (unpublished). FigAA 
shows the time-course of release of ‘251-labeled 
material from adipocytes y-loaded with [ *251]in- 
sulin or 1251-labeled [LeuB 4]insul~n. It can be seen 
that the rate of release of ‘251-labeled material from 
cells loaded with ‘251-labeled [LeuB24finsulin is the 
same as from cells loaded with [ ‘251]insulin. 
Furthermore, the trichloroacetic acid solubility of 
the material released from the 2 groups of cells was 
about equal at each time point (fig.B). This method 
(trichloroacetic acid solubility) assesses receptor 
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Fig.4. Receptor-mediated egradation of [ t251]insulin 
and ‘251-labeled [LeuB24]insulin. Adipocytes (- 4 x 105) 
were incubated with [ 
labeled [LeuB24]insulin 
1251]insulin (0.4 ng/ml) or 1251- 
(2 ng/ml) for 90 min at 24°C. 
Cells were then separated from medium, washed once in 
ice-cold buffer, re-suspended at 2 x IO5 cells/ml and 
incubated at 24” C. At the indicated times the amount of 
‘251-labeled material remaining bound to the cells (A) 
and the trichloroacetic acid solubility of the material re- 
leased into the medium (B) were determined. (0) 
[1251]insulin; (o) ‘251-labeled [LeuB24]insulin. 
251 
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mediated degradation to low-M, products (mostly 
‘251- and iodotyrosine) and thus provides a mea- 
surement of the overall rate for processing the hor- 
mone to its final degradation products. However, 
althou h the 
[LeuB2G 
overall rate of degradation of 
]msulm 1s indistinguishable from that of the 
native hormone, recent experiments have identified 
differences among peptide intermediates of insulin 
and [LeuB24 ’ Iinsulin metabolism by isolated hepa- 
tocytes (H.T. et al., unpublished). 
These experiments demonstrate that [LeuB24]in- 
sulin is internalized at the same rate as insulin, and 
that the overall rate of degradation of the hormone 
to low-M, products is also comparable to that of the 
native hormone. Thus, an amino acid substitution 
in the receptor binding portion of the insulin mol- 
ecule did not alter its overall rate of internalization or 
degradation, despite a marked decrease in binding 
affinity. Therefore the overall rates of recep- 
tor-mediated insulin internalization and degrada- 
tion depend on the degree of hormone receptor 
occupancy, rather than on hormone structure. Al- 
though details of the intermediate proteolytic 
events in insulin degradation may involve elements 
of substrate specificity, our results show that the 
receptor binding region is not recognized in the 
degradative process subsequent to the binding 
event. 
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